$2m fund puts researchers on the fast track
Commercialisation
The ÐÓ°ÉÖ±²¥ of Adelaide aims to put more of its research discoveries on the path to commercialisation with a new $2 million fund for researchers. The Commercial Accelerator Scheme was launched recently by the ÐÓ°ÉÖ±²¥'s commercial development company . Under the scheme, ÐÓ°ÉÖ±²¥ of Adelaide researchers can receive up to $250,000 to make their project "investment ready". It will address a recognised gap in research funding known as the "valley of death" between traditional research funding and venture capital. ÐÓ°ÉÖ±²¥ of Adelaide Vice-Chancellor and President Professor James McWha said: "With the introduction of the Commercial Accelerator Scheme we hope to be able to continue to increase the number of successful commercial ventures at the ÐÓ°ÉÖ±²¥ of Adelaide - to add to the already significant list of commercial successes we've had. "Venture capital funds typically don't invest in research until they have a product or prototype. The Commercial Accelerator Scheme will provide funding so researchers can establish proof-of-concept or reach a development milestone necessary to attract a commercial partner. "Federal and State Government grant programs are also essential for research and development and this scheme complements these programs to take this research towards commercial development." ÐÓ°ÉÖ±²¥ of Adelaide commercial success stories include:
- Bresagen Ltd - the first biotech start-up company in ÐÓ°ÉÖ±²¥;
- GroPep Ltd - a biopharmaceutical company recently taken over by Danish company Novozymes;
- New cereal varieties bred at the ÐÓ°ÉÖ±²¥'s Waite Campus;
- The developers of the Sydney Olympic torch fuel and flame system; and
- Mudpack Software, licensed to power companies to assist in managing blackouts.
Story by Robyn Mills
|